Literature DB >> 21930446

Nationwide prediction of future expenditure for protease inhibitors in chronic hepatitis C.

Dario Maratea, Andrea Messori, Valeria Fadda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21930446     DOI： 10.1016/j.dld.2011.08.016

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  4 in total

1.  Effect of discounting on estimation of benefits determined by hepatitis C treatment.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

Review 2.  Protease inhibitors for hepatitis C: economic implications.

Authors:  Stuart J Turner; Jack Brown; Joseph A Paladino
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

3.  New and old anti-thrombotic treatments for patients with atrial fibrillation.

Authors:  Andrea Messori; Dario Maratea; Valeria Fadda; Sabrina Trippoli
Journal:  Int J Clin Pharm       Date:  2013-06

4.  Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.

Authors:  Jennifer Ann Kieran; Suzanne Norris; Aisling O'Leary; Cathal Walsh; Raphael Merriman; D Houlihan; P Aiden McCormick; Susan McKiernan; Colm Bergin; Michael Barry
Journal:  BMC Infect Dis       Date:  2015-10-26       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.